(Total Views: 81)
 Posted On: 12/09/2024 1:44:22 PM 
  
		  		    Post#  of 145504		    
			
		      
  
	$DYAI Dyadic Receives $3 Million Grant to Develop Cost-Effective Monoclonal Antibodies for RSV and Malaria Using C1 Platform Technology https://finance.yahoo.com/news/dyadic-receive...00271.html
 	
 
 (0)
(0) (0)
(0) 
      			 
 
  
    
      
    












